Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients

Completed · Phase 2 · Has a placebo group

Conditions studied: Postoperative Nausea and Vomiting, Abdominal Pain

In brief

The purpose of this study is to determine whether Bisacodyl, 5 mg usage decreases the incidence of nausea and abdominal pain after surgery, and also decreases the number of hospitalization days.

Key facts

Study ID

NCT01011426

Run by

The Cooper Health System

People needed

285

Starts

2009-04-01

Expected to finish

2012-06-01

Last updated by the study team

2014-01-20

Who can join

Age: 12 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Obstetrical and gynecological patients undergoing abdominal surgery.

You may not qualify if…

• Subjects undergoing a bowel resection.
• Subjects who have a nasogastric tube for bowel decompression.
• Subjects allergic to Bisacodyl.
• Subjects with mechanical bowel obstruction undergoing bowel resection.

Where it is running

• Cooper University Hospital — Camden, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.